Idarubicin-loaded methoxy poly(ethylene glycol)-b-poly(l-lactide-co-glycolide) nanoparticles for enhancing cellular uptake and promoting antileukemia activity

References

• WoutersBJDelwelREpigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemiaBlood20161271425226660432
   PubMed Web of Science ®Google Scholar
• DombretHGardinCAn update of current treatments for adult acute myeloid leukemiaBlood20161271536126660429
   PubMed Web of Science ®Google Scholar
• OunRMoussaYEWheateNJThe side effects of platinum-based chemotherapy drugs: a review for chemistsDalton Trans2018476645665329632935
   PubMed Web of Science ®Google Scholar
• BermanEHellerGSantorsaJResults of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemiaBlood1991778166616742015395
   PubMed Web of Science ®Google Scholar
• GalloisLFialloMGarnier-SuillerotAComparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism studyBiochim Biophys Acta19981370131409518541
   PubMed Web of Science ®Google Scholar
• OhtakeSMiyawakiSFujitaHRandomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 StudyBlood201111782358236520693429
   PubMed Web of Science ®Google Scholar
• LiuHFuRLiLComparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid LeukemiaClin Drug Investig2017372167174
   PubMedGoogle Scholar
• DuttaRCDrug carriers in pharmaceutical design: promises and progressCurr Pharm Des200713776176917346190
   PubMed Web of Science ®Google Scholar
• YuanYYMaoCQDuXJDuJZWangFWangJSurface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumorAdv Mater201224405476548022886872
   PubMed Web of Science ®Google Scholar
• MisraRSahooSKCoformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cellsMol Pharm20118385286621480667
   PubMed Web of Science ®Google Scholar
• YadavKSSawantKKModified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticlesAAPS PharmSciTech20101131456146520842542
   PubMed Web of Science ®Google Scholar
• AnXZhuALuoHKeHChenHZhaoYRational Design of Multi-Stimuli-Responsive Nanoparticles for Precise Cancer TherapyACS Nano20161065947595827285378
   PubMed Web of Science ®Google Scholar
• MohantyCSahooSKThe in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulationBiomaterials201031256597661120553984
   PubMed Web of Science ®Google Scholar
• DilnawazFSinghAMohantyCSahooSKDual drug loaded super-paramagnetic iron oxide nanoparticles for targeted cancer therapyBiomaterials201031133694370620144478
   PubMed Web of Science ®Google Scholar
• JiangXHuangHLiZBlockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemiaCancer Cell201222452453523079661
   PubMed Web of Science ®Google Scholar
• LiZChenPSuROverexpression and knockout of miR-126 both promote leukemogenesisBlood2015126172005201526361793
   PubMed Web of Science ®Google Scholar
• XiongWPengLChenHLiQSurface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapyInt J Nanomedicine2015102985299625945046
   PubMed Web of Science ®Google Scholar
• RakhmatullinRMKurkinINPavlovVVSemashkoVVEPR, optical, and dielectric spectroscopy of Er-doped cerium dioxide nanoparticlesPhysica Status Solidi2014251815451551
   Google Scholar
• AcharyaSSahooSKPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdv Drug Deliv Rev201163317018320965219
   PubMed Web of Science ®Google Scholar
• ZengXTaoWMeiLHuangLTanCFengSSCholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancerBiomaterials201334256058606723694904
   PubMed Web of Science ®Google Scholar
• LiuTSeiffertSThieleJAbateARWeitzDARichteringWNon-coalescence of oppositely charged droplets in pH-sensitive emulsionsProc Natl Acad Sci U S A2012109238438922203968
   PubMedGoogle Scholar
• KrivtsovAVTwomeyDFengZTransformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9Nature2006442710481882216862118
   PubMed Web of Science ®Google Scholar
• ZhangYSunTJiangCBiomacromolecules as carriers in drug delivery and tissue engineeringActa Pharm Sin B201881345029872621
   PubMed Web of Science ®Google Scholar
• MaPDongXSwadleyCLDevelopment of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemiaJ Biomed Nanotechnol20095215116120055093
   PubMed Web of Science ®Google Scholar
• JainRDandekarPLoretzBEnhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcoholInt J Pharm2011420114715521884767
   PubMedGoogle Scholar
• GunduzUKeskinTTansıkGIdarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancerBiomed Pharmacother201468672973625194441
   PubMed Web of Science ®Google Scholar
• MaifredeSMartinezENieborowska-SkorskaMMLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugsBlood Adv20171191467147229296788
   PubMedGoogle Scholar
• PikmanYPuissantAAlexeGTargeting MTHFD2 in acute myeloid leukemiaJ Exp Med201621371285130627325891
   PubMedGoogle Scholar
• DharSKolishettiNLippardSJFarokhzadOCTargeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivoProc Natl Acad Sci U S A201110851850185521233423
   PubMed Web of Science ®Google Scholar
• WangXLiJWangYA folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer modelACS Nano2011586184619421728341
   PubMed Web of Science ®Google Scholar
• KrishnanVXuXBarweSPDexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicineMol Pharm20131062199221023194373
   PubMed Web of Science ®Google Scholar
• FujishimaMFujishimaNKitadateASuccessful management of splenomegaly with ruxolitinib prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia transformed from post-polycythemia vera myelofibrosisRinsho Ketsueki201758774374828781268
   PubMedGoogle Scholar
• NguyenATTaranovaOHeJZhangYDOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesisBlood2011117256912692221521783
   PubMed Web of Science ®Google Scholar
• LocatelliEGilLIsraelLLBiocompatible nanocomposite for PET/MRI hybrid imagingInt J Nanomedicine201276021603323271907
   PubMed Web of Science ®Google Scholar
• DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
   PubMed Web of Science ®Google Scholar
• TamboriniMLocatelliERasileMA Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in GlioblastomaACS Nano20161022509252026745323
   PubMedGoogle Scholar
• DuoXLiQWangJCore/Shell Gene Carriers with Different Lengths of PLGA Chains to Transfect Endothelial CellsLangmuir20173346133151332529100464
   PubMedGoogle Scholar
• AvgoustakisKBeletsiAPanagiZEffect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticlesInt J Pharm20032591–211512712787641
   PubMed Web of Science ®Google Scholar
• GryparisECHatziapostolouMPapadimitriouEAvgoustakisKAnticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cellsEur J Pharm Biopharm20076711817303395
   PubMed Web of Science ®Google Scholar
• WalterRBAppelbaumFREsteyEHBernsteinIDAcute myeloid leukemia stem cells and CD33-targeted immunotherapyBlood2012119266198620822286199
   PubMed Web of Science ®Google Scholar